Page last updated: 2024-11-06

mitomycin and Behcet Syndrome

mitomycin has been researched along with Behcet Syndrome in 4 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.

Research Excerpts

ExcerptRelevanceReference
"To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients."7.85Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017)
"To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period."7.74Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007)
"To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease."7.72Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004)
"To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Behçet disease (BD) patients."3.85Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients. ( Aihara, M; Fujino, Y; Kaburaki, T; Komae, K; Matsuda, J; Nakahara, H; Ohtomo, K; Okinaga, K; Takamoto, M; Tanaka, R, 2017)
"To determine the outcome of initial trabeculectomy with mitomycin C (MMC) in the management of secondary glaucoma associated with Behçet disease (BD) in a 1-year follow-up period."3.74Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease. ( Batman, A; Berker, N; Elgin, U; Soykan, E, 2007)
"To determine the effect of intraoperative application of Mitomycin-C (MMC) with trabeculectomy in uveitic glaucoma associated with Behçet disease."3.72Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease. ( Duman, S; Eksioglu, U; Sungur, G; Turhan, E; Yalvac, IS, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komae, K1
Takamoto, M1
Tanaka, R1
Aihara, M1
Ohtomo, K1
Okinaga, K1
Matsuda, J1
Nakahara, H1
Fujino, Y1
Kaburaki, T1
Yalvac, IS1
Sungur, G1
Turhan, E1
Eksioglu, U1
Duman, S1
Elgin, U1
Berker, N1
Batman, A1
Soykan, E1
Peavy, DL1
Nelms, DC1
Mackler, BF1

Other Studies

4 other studies available for mitomycin and Behcet Syndrome

ArticleYear
Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients.
    Journal of glaucoma, 2017, Volume: 26, Issue:7

    Topics: Adult; Alkylating Agents; Behcet Syndrome; Combined Modality Therapy; Conjunctiva; Female; Glaucoma;

2017
Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease.
    Journal of glaucoma, 2004, Volume: 13, Issue:6

    Topics: Adolescent; Adult; Aged; Behcet Syndrome; Chemotherapy, Adjuvant; Female; Glaucoma; Humans; Intraocu

2004
Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease.
    Journal of glaucoma, 2007, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antihypertensive Agents; Behcet Syndrome; Combined M

2007
Failure of autologous oral epithelia to activate RAS lymphocytes.
    Clinical immunology and immunopathology, 1982, Volume: 22, Issue:2

    Topics: Behcet Syndrome; Epithelial Cells; Epithelium; Humans; Lymphocyte Activation; Mitomycin; Mitomycins;

1982